Emerging Pharmaceutical Therapies to Address the Inadequacy of a Gluten-Free Diet for Celiac Disease

• Egile Nagusiak: Martina Crepaldi (Egilea), Michela Palo (Egilea), Daria Maniero (Egilea), Luisa Bertin (Egilea), Edoardo Vincenzo Savarino (Egilea), Robert P. Anderson (Egilea), Fabiana Zingone (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2023-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Celiac disease (CeD) is a chronic autoimmune disorder triggered by the ingestion of gluten, affecting around 1% of the global population. It is a multifactorial disease involving both genetics and environmental factors. Nowadays, the only available treatment for CeD is a life-long gluten-free diet (...